Hippocampal sclerosis and epilepsy surgery in neurofibromatosis type 1: case report of a 3-year-old child explored by SEEG and review of the literature

Childs Nerv Syst. 2022 Jun;38(6):1217-1221. doi: 10.1007/s00381-021-05343-0. Epub 2021 Sep 10.

Abstract

Purpose: Epilepsy associated with neurofibromatosis type 1 (NF1) is infrequent and usually controlled with anti-epileptic drugs. However, in some drug-resistant patients a presurgical evaluation should be considered. Hippocampal sclerosis (HS) is one of the rare causes of epilepsy in neurofibromatosis type 1, which can lead to surgery.

Methods: We present a three-year-old child with refractory epilepsy associated with several structural brain abnormalities but normal hippocampi on brain MRI and a heterozygous variant in the NF1 gene (c.2542G > A). A complete presurgical evaluation was performed including stereo-electroencephalography (SEEG).

Results: Usual seizures were recorded, and the seizure onset zone was delineated in the anterior hippocampus. Pathological examination performed after a tailored mesio-temporal resection confirmed hippocampal sclerosis, and the child achieved seizure freedom with 2 years of follow-up.

Conclusion: This rare pediatric case illustrates that NF1 may be associated with early-onset refractory epilepsy secondary to MRI-negative HS, supporting the major role of SEEG in the presurgical evaluation of patients with extended cortical malformations.

Keywords: Children; Drug-resistant epilepsy; Invasive recording; Mesio-temporal epilepsy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Child
  • Child, Preschool
  • Drug Resistant Epilepsy* / diagnostic imaging
  • Drug Resistant Epilepsy* / etiology
  • Drug Resistant Epilepsy* / surgery
  • Electroencephalography
  • Epilepsy* / etiology
  • Hippocampus / diagnostic imaging
  • Hippocampus / pathology
  • Hippocampus / surgery
  • Humans
  • Magnetic Resonance Imaging / adverse effects
  • Neurodegenerative Diseases*
  • Neurofibromatosis 1* / complications
  • Neurofibromatosis 1* / diagnostic imaging
  • Neurofibromatosis 1* / surgery
  • Sclerosis / etiology
  • Sclerosis / pathology
  • Seizures / complications
  • Treatment Outcome